AI-Guided (GenAIS TM) Versus Standard Physician-Guided Dietary Supplementation for Managing Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

May 20, 2024

Study Completion Date

June 5, 2024

Conditions
Metabolic Syndrome
Interventions
OTHER

Standard therapy group

Participants receive DS prescriptions from a physician based on current standard practices, which include biochemical markers, genetic data, and metabolic profiles.

OTHER

AI-Guided Group

Participants receive DS prescriptions determined by GenAIS, is an AI system that considers genetic data, metabolic profiles, biochemical markers, and patient history.

Trial Locations (1)

630090

Center of New Medical Technologies, Novosibirsk

All Listed Sponsors
lead

S.LAB (SOLOWAYS)

OTHER